Vismodegib is an active pharmaceutical ingredient used in antineoplastic medications. According to authoritative sources, it is associated with developmental toxicity and reproductive toxicity risks.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Restricted or banned substances
Substances on this list are banned or restricted under the named regulation. This page is a compliance reference — verify your obligations under applicable law.
CAS 879085-55-9
Des(1-hydroxy-1-methylethyl)-(1-methylethenyl)-olmesartan medoxomil
pharmaceutical raw material
Chloroxylenol
pharmaceutical raw material
N-adamantylacetamide
pharmaceutical raw material
Cefepime
pharmaceutical raw material
The international HS code for Vismodegib (CAS 879085-55-9) is 2933.39.
2933.39
2933 39 99
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-chloro-N-(4-chloro-3-pyridin-2-ylphenyl)-4-methylsulfonylbenzamide
BPQMGSKTAYIVFO-UHFFFAOYSA-N
CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl